The University of Chicago Header Logo

Connection

Valluvan Jeevanandam to Heart Transplantation

Back to Details
This is a "connection" page, showing publications Valluvan Jeevanandam has written about Heart Transplantation.
Valluvan Jeevanandam
Connection Strength
8.378
Heart Transplantation
  1. Commentary: Warm ischemic injury to human donor hearts-when is it too much? J Thorac Cardiovasc Surg. 2024 Apr; 167(4):1361-1362.
    View in: PubMed
    Score: 0.590
  2. Does PTFE coverage facilitate LVAD explant and heart transplant? J Card Surg. 2022 12; 37(12):4324.
    View in: PubMed
    Score: 0.547
  3. Commentary: Redo heart transplantation: Lessons learned over the past 20 years. J Thorac Cardiovasc Surg. 2023 Aug; 166(2):595-596.
    View in: PubMed
    Score: 0.512
  4. Improving the metrics for donor heart sizing. J Card Surg. 2021 Sep; 36(9):3250.
    View in: PubMed
    Score: 0.502
  5. A successful heart and liver transplantation requiring intraoperative extracorporeal membrane oxygenation for primary cardiac allograft dysfunction in a patient with Fontan failure. J Card Surg. 2020 Jun; 35(6):1357-1359.
    View in: PubMed
    Score: 0.463
  6. Successful use of ECMO in a Jehovah's Witness after complicated re-heart transplant. ASAIO J. 2013 Sep-Oct; 59(5):528-9.
    View in: PubMed
    Score: 0.292
  7. Improving donor organ function-cold to warm preservation. World J Surg. 2010 Apr; 34(4):628-31.
    View in: PubMed
    Score: 0.231
  8. Invited commentary. Ann Thorac Surg. 2007 May; 83(5):1696.
    View in: PubMed
    Score: 0.188
  9. Donor tricuspid annuloplasty during orthotopic heart transplantation: long-term results of a prospective controlled study. Ann Thorac Surg. 2006 Dec; 82(6):2089-95; discussion 2095.
    View in: PubMed
    Score: 0.183
  10. Donor Selection for Heart Transplantation in 2025. JACC Heart Fail. 2025 Mar; 13(3):389-401.
    View in: PubMed
    Score: 0.159
  11. A one-year comparison of prophylactic donor tricuspid annuloplasty in heart transplantation. Ann Thorac Surg. 2004 Sep; 78(3):759-66; discussion 759-66.
    View in: PubMed
    Score: 0.157
  12. Summary of a consensus conference on heart-liver transplantation. Am J Transplant. 2024 Mar; 24(3):380-390.
    View in: PubMed
    Score: 0.149
  13. Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation. J Cardiothorac Surg. 2023 Oct 12; 18(1):288.
    View in: PubMed
    Score: 0.147
  14. Rigid sternal fixation in the cardiac transplant population. J Thorac Cardiovasc Surg. 2003 Sep; 126(3):896-7.
    View in: PubMed
    Score: 0.146
  15. The American Association for Thoracic Surgery 2023 Expert Consensus Document: Adult cardiac transplantation utilizing donors after circulatory death. J Thorac Cardiovasc Surg. 2023 09; 166(3):856-869.e5.
    View in: PubMed
    Score: 0.144
  16. Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
    View in: PubMed
    Score: 0.142
  17. Clinical outcomes of grafted vs. percutaneous axillary intra-aortic balloon pump support as a bridge to transplantation: a propensity score-matched analysis. Heart Vessels. 2022 Dec; 37(12):1995-2001.
    View in: PubMed
    Score: 0.135
  18. Comparing short-term/long-term outcomes of heart transplants that occur inside and outside of normal working hours. ESC Heart Fail. 2022 08; 9(4):2484-2490.
    View in: PubMed
    Score: 0.133
  19. Combined heart-liver-kidney transplant: The university of Chicago medicine experience. Clin Transplant. 2022 04; 36(4):e14586.
    View in: PubMed
    Score: 0.131
  20. Ten-year, single center experience of ambulatory axillary intra-aortic balloon pump support for heart failure. J Cardiol. 2022 05; 79(5):611-617.
    View in: PubMed
    Score: 0.130
  21. Outcomes From Three Decades of Infant and Pediatric Heart Transplantation. ASAIO J. 2021 09 01; 67(9):1051-1059.
    View in: PubMed
    Score: 0.127
  22. Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes. Hepatology. 2021 04; 73(4):1464-1477.
    View in: PubMed
    Score: 0.124
  23. Orthotopic heart transplantation with persistent left superior vena cava draining into coronary sinus: the anterior rerouting technique. Gen Thorac Cardiovasc Surg. 2021 Apr; 69(4):673-678.
    View in: PubMed
    Score: 0.120
  24. Outcomes of Ambulatory Axillary Intraaortic Balloon Pump as a Bridge to Heart Transplantation. Ann Thorac Surg. 2021 04; 111(4):1264-1270.
    View in: PubMed
    Score: 0.119
  25. Increasing heart transplant donor pool by liberalization of size matching. J Heart Lung Transplant. 2019 11; 38(11):1197-1205.
    View in: PubMed
    Score: 0.111
  26. Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. J Heart Lung Transplant. 2019 09; 38(9):997-999.
    View in: PubMed
    Score: 0.109
  27. Increase in short-term risk of rejection in heart transplant patients receiving granulocyte colony-stimulating factor. J Heart Lung Transplant. 2018 11; 37(11):1322-1328.
    View in: PubMed
    Score: 0.102
  28. Consequences of Retained Defibrillator and Pacemaker Leads After Heart Transplantation-An Underrecognized Problem. J Card Fail. 2018 02; 24(2):101-108.
    View in: PubMed
    Score: 0.099
  29. The role of gender in heart transplantation. Ann Thorac Surg. 1998 Jan; 65(1):88-94.
    View in: PubMed
    Score: 0.099
  30. Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg. 1997 Jul; 64(1):142-7.
    View in: PubMed
    Score: 0.095
  31. Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States. Am J Transplant. 2017 Oct; 17(10):2559-2566.
    View in: PubMed
    Score: 0.095
  32. Accepting Hearts From Hepatitis C-Positive Donor: Can We Expand the Donor Pool? J Card Fail. 2017 Oct; 23(10):762-764.
    View in: PubMed
    Score: 0.095
  33. Triiodothyronine: spectrum of use in heart transplantation. Thyroid. 1997 Feb; 7(1):139-45.
    View in: PubMed
    Score: 0.093
  34. Intravenous vitamin K1 prior to orthotopic heart transplantation: effects in vivo and in vitro. Acta Anaesthesiol Scand. 1997 Jan; 41(1 Pt 1):78-83.
    View in: PubMed
    Score: 0.092
  35. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function. Clin Transplant. 1996 Dec; 10(6 Pt 2):639-45.
    View in: PubMed
    Score: 0.092
  36. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg. 1996 Nov; 62(5):1268-75.
    View in: PubMed
    Score: 0.091
  37. Defining the role of aprotinin in heart transplantation. Ann Thorac Surg. 1996 Sep; 62(3):670-4.
    View in: PubMed
    Score: 0.090
  38. Recipient-donor atrial synchronization benefits acute hemodynamics after orthotopic heart transplantation. J Heart Lung Transplant. 1996 Apr; 15(4):368-70.
    View in: PubMed
    Score: 0.087
  39. Surgical management of cardiac pheochromocytoma. Resection versus transplantation. Ann Surg. 1995 Apr; 221(4):415-9.
    View in: PubMed
    Score: 0.082
  40. Adult orthotopic heart transplantation using undersized pediatric donor hearts. Technique and postoperative management. Circulation. 1994 Nov; 90(5 Pt 2):II74-7.
    View in: PubMed
    Score: 0.079
  41. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant. 1994 Jul-Aug; 13(4):681-7; discussion 685-7.
    View in: PubMed
    Score: 0.077
  42. Use of triiodothyronine replacement therapy to reverse donor myocardial dysfunction: creating a larger donor pool. Transplant Proc. 1993 Dec; 25(6):3305-6.
    View in: PubMed
    Score: 0.074
  43. The implantable defibrillator: an electronic bridge to cardiac transplantation. Circulation. 1992 Nov; 86(5 Suppl):II276-9.
    View in: PubMed
    Score: 0.069
  44. Cardiac transplantation after prolonged graft preservation with the University of Wisconsin solution. J Thorac Cardiovasc Surg. 1992 Aug; 104(2):224-8.
    View in: PubMed
    Score: 0.068
  45. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012 Jun 26; 125(25):3191-200.
    View in: PubMed
    Score: 0.067
  46. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial. J Thorac Cardiovasc Surg. 1992 Feb; 103(2):194-8; discussion 198-9.
    View in: PubMed
    Score: 0.065
  47. Improved heart preservation with University of Wisconsin solution: experimental and preliminary human experience. Circulation. 1991 Nov; 84(5 Suppl):III324-8.
    View in: PubMed
    Score: 0.064
  48. Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg. 2011 Aug; 92(2):520-7; discussion 527.
    View in: PubMed
    Score: 0.063
  49. Extending the limits of donor heart preservation: a trial with University of Wisconsin solution. Transplant Proc. 1991 Feb; 23(1 Pt 1):697-8.
    View in: PubMed
    Score: 0.061
  50. Activation of JAK-STAT and nitric oxide signaling as a mechanism for donor heart dysfunction. J Heart Lung Transplant. 2010 Mar; 29(3):346-51.
    View in: PubMed
    Score: 0.057
  51. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant. 2008 Jul; 27(7):753-9.
    View in: PubMed
    Score: 0.051
  52. Identical alpha-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of human cardiac allografts with chronic rejection. Cell Immunol. 2003 Oct; 225(2):75-90.
    View in: PubMed
    Score: 0.037
  53. A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg. 2001 May; 71(5):1442-7.
    View in: PubMed
    Score: 0.031
  54. Simultaneous heart and kidney transplantation in patients with end-stage heart and renal failure. Am J Transplant. 2001 May; 1(1):89-92.
    View in: PubMed
    Score: 0.031
  55. Apoptosis in chronic rejection of human cardiac allografts. Transplantation. 2001 Apr 27; 71(8):1137-46.
    View in: PubMed
    Score: 0.031
  56. Gamma-chain T-cell receptor transcripts are clonally expanded in the coronary arteries of cardiac allografts from patients with chronic rejection. Transplant Proc. 2001 Feb-Mar; 33(1-2):456-8.
    View in: PubMed
    Score: 0.031
  57. Coronary arteries from human cardiac allografts with chronic rejection contain oligoclonal T cells: persistence of identical clonally expanded TCR transcripts from the early post-transplantation period (endomyocardial biopsies) to chronic rejection (coronary arteries). J Immunol. 2000 Sep 15; 165(6):3469-83.
    View in: PubMed
    Score: 0.030
  58. Balloon-expandable stent placement for superior vena cava-right atrial stenosis after heart transplantation. J Heart Lung Transplant. 2000 Jul; 19(7):705-9.
    View in: PubMed
    Score: 0.029
  59. Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial. Circ Heart Fail. 2020 04; 13(4):e006666.
    View in: PubMed
    Score: 0.029
  60. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med. 1998 Dec 10; 339(24):1744-51.
    View in: PubMed
    Score: 0.026
  61. Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year. Transplant Proc. 1998 Aug; 30(5):1892-4.
    View in: PubMed
    Score: 0.026
  62. T cells infiltrating coronary arteries of cardiac allografts with chronic rejection contain clonally expanded T lymphocytes. Transplant Proc. 1998 Jun; 30(4):1002-4.
    View in: PubMed
    Score: 0.025
  63. The C-Port Distal Coronary Anastomotic Device Is Comparable With a Hand-Sewn Anastomosis: Human Histological Case Study. Innovations (Phila). 2018 Mar/Apr; 13(2):140-143.
    View in: PubMed
    Score: 0.025
  64. Adverse Event Rates Change Favorably Over Time for Patients Bridged With the HeartWare Left Ventricular Assist Device. ASAIO J. 2017 Nov-Dec; 63(6):745-751.
    View in: PubMed
    Score: 0.024
  65. Eliminating bradyarrhythmias after orthotopic heart transplantation. Circulation. 1996 Nov 01; 94(9 Suppl):II278-82.
    View in: PubMed
    Score: 0.023
  66. Evidence supports severe renal insufficiency as a relative contraindication to heart transplantation. J Heart Lung Transplant. 2016 07; 35(7):893-900.
    View in: PubMed
    Score: 0.022
  67. Functional and morphologic adaptation of undersized donor hearts after heart transplantation. J Am Coll Cardiol. 1995 Sep; 26(3):737-42.
    View in: PubMed
    Score: 0.021
  68. Electrophysiologic effects of intravenous aminophylline in heart transplant recipients with sinus node dysfunction. J Heart Lung Transplant. 1995 May-Jun; 14(3):429-35.
    View in: PubMed
    Score: 0.020
  69. Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System. JACC Heart Fail. 2015 Apr; 3(4):303-13.
    View in: PubMed
    Score: 0.020
  70. Radiofrequency ablation of Wolff-Parkinson-White syndrome in a donor heart after orthotopic heart transplantation. J Heart Lung Transplant. 1994 Sep-Oct; 13(5):905-9.
    View in: PubMed
    Score: 0.020
  71. Endomyocardial biopsy under transesophageal echocardiographic guidance can be safely performed in the critically ill cardiac transplant recipient. Am J Cardiol. 1994 May 15; 73(13):1019-20.
    View in: PubMed
    Score: 0.019
  72. Novel preservation solution permits 24-hour preservation in rat and baboon cardiac transplant models. Circulation. 1993 Nov; 88(5 Pt 2):II291-7.
    View in: PubMed
    Score: 0.018
  73. Intra-aortic balloon pump inserted through the subclavian artery: A minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):951-5.
    View in: PubMed
    Score: 0.017
  74. University of Wisconsin solution for human donor heart preservation: initial clinical experience. Ann Thorac Surg. 1991 Dec; 52(6):1213-6.
    View in: PubMed
    Score: 0.016
  75. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 1998 Aug 18; 98(7):656-62.
    View in: PubMed
    Score: 0.006
  76. Postpartum multivessel coronary dissection. J Heart Lung Transplant. 1994 May-Jun; 13(3):533-7.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.